Hye Khan MA

References (4)

Title : Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice - Hye Khan_2025_Eur.J.Pharmacol_1006_178132
Author(s) : Hye Khan MA , Goorani S , Atamanchuk A , Jankiewicz W , Yeboah MM , Barnett SD , Falck JR , Hwang SH , Barnych B , Hammock BD , El-Meanawy A , Imig JD
Ref : European Journal of Pharmacology , 1006 :178132 , 2025
Abstract :
PubMedSearch : Hye Khan_2025_Eur.J.Pharmacol_1006_178132
PubMedID: 40946955

Title : Multitarget molecule,PTUPB, to treat diabetic nephropathy in rats - Hye_2021_Br.J.Pharmacol_178_4468
Author(s) : Hye Khan MA , Hwang SH , Barnett SD , Stavniichuk A , Jankiewicz WK , Hammock BD , Imig JD
Ref : British Journal of Pharmacology , 178 :4468 , 2021
Abstract :
PubMedSearch : Hye_2021_Br.J.Pharmacol_178_4468
PubMedID: 34255857

Title : Dual Soluble Epoxide Hydrolase Inhibitor\/PPAR-gamma Agonist Attenuates Renal Fibrosis - Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
Author(s) : Stavniichuk A , Hye Khan MA , Yeboah MM , Chesnik MA , Jankiewicz WK , Hartmann M , Blocher R , Kircher T , Savchuk O , Proschak E , Imig JD
Ref : Prostaglandins Other Lipid Mediat , :106472 , 2020
Abstract :
PubMedSearch : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
PubMedID: 32569747

Title : A dual farnesoid X receptor\/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice - Hye_2019_Biochem.Pharmacol_166_212
Author(s) : Hye Khan MA , Schmidt J , Stavniichuk A , Imig JD , Merk D
Ref : Biochemical Pharmacology , 166 :212 , 2019
Abstract :
PubMedSearch : Hye_2019_Biochem.Pharmacol_166_212
PubMedID: 31129048